. However, the factors that influence continued clearance by phagocytes are not known. Here we show that the mitochondrial membrane potential of the phagocyte critically controls engulfment capacity, with lower potential enhancing engulfment and vice versa. The mitochondrial membrane protein Ucp2, which acts to lower the mitochondrial membrane potential [7] [8] [9] , was upregulated in phagocytes engulfing apoptotic cells. Loss of Ucp2 reduced phagocytic capacity, whereas Ucp2 overexpression enhanced engulfment. Mutational and pharmacological studies indicated a direct role for Ucp2-mediated mitochondrial function in phagocytosis. Macrophages from Ucp2-deficient mice 10, 11 were impaired in phagocytosis in vitro, and Ucp2-deficient mice showed profound in vivo defects in clearing dying cells in the thymus and testes. Collectively, these data indicate that mitochondrial membrane potential and Ucp2 are key molecular determinants of apoptotic cell clearance. As Ucp2 is linked to metabolic diseases and atherosclerosis 11, 12 , this newly discovered role for Ucp2 in apoptotic cell clearance has implications for the complex aetiology and pathogenesis of these diseases.
When a phagocyte engulfs a dying cell it essentially doubles its cellular contents. Yet phagocytes often ingest multiple apoptotic cells sequentially, and the factors regulating the 'engulfment capacity' of a given phagocyte are not understood. Because metabolites derived from the ingested apoptotic cells could influence phagocyte mitochondrial function, we asked whether the phagocyte mitochondrial membrane potential is altered. Phagocytes labelled with the dyes JC-1 (the red-togreen fluorescence ratio of which depends on mitochondrial membrane potential 13 ; Supplementary Fig. 1a ) or TMRE were incubated with apoptotic thymocytes for different periods of time. To focus on phagocytes with ingested targets, the thymocytes were labelled with cypHer5E, a pH-dependent dye for which the fluorescence increases after the apoptotic corpse enters the acidic phagolysosome. There was a significant increase in the relative mitochondrial membrane potential in phagocytes with engulfed targets (1.99-fold 6 0.11, P , 0.001, n 5 6) compared to non-engulfing phagocytes within the same population ( Fig. 1a and Supplementary Fig. 1b ). The enhanced mitochondrial membrane potential was not derived from the apoptotic thymocytes ( Supplementary Fig. 1c ). Remarkably, phagocytes ingesting synthetic targets showed no increase in mitochondrial membrane potential ( Fig. 1a and Supplementary Fig. 1b) , even though the synthetic targets use components of the apoptotic cell engulfment machinery 14 . As the synthetic targets do not have a metabolic load, the higher mitochondrial membrane potential could not be attributed to a general effect of engulfment. The mitochondrial membrane potential returned to baseline over the next few hours (Fig. 1b) . In general, cellular ATP levels are maintained within a fairly narrow range and the engulfing phagocytes had a modest 10% increase in cellular ATP at the 2-h point ( Supplementary Fig. 1d ). Therefore, the return to baseline of the mitochondrial membrane potential within phagocytes suggested a mechanism for uncoupling nutrient oxidation from ATP generation 8 . A well-known mechanism for uncoupling the proton gradient and ATP generation is mediated by uncoupling proteins (UCPs) 8 . UCPs regulate the mitochondrial membrane potential through dissipation of the proton gradient across the inner mitochondrial membrane, without ATP generation. Compared to Ucp1 (restricted to brown adipose tissue) 15 , Ucp2 is more ubiquitously expressed 8 , with expression also occurring in several phagocytic cell types ( Supplementary Fig. 2a ). Whereas messenger RNA levels of Ucp2 were not detectably altered within engulfing phagocytes, mitochondrial Ucp2 protein levels increased after incubation with apoptotic cells (Fig. 1c , left, and Supplementary Fig. 2b, c) . The higher Ucp2 protein levels were not derived from ingested targets, as Ucp2 levels in thymocytes were below detection, and Ucp2-deficient apoptotic thymocytes used as targets also enhanced Ucp2 protein levels in phagocytes ( Fig. 1c and Supplementary Fig. 2d ). The synthetic targets did not induce higher levels of Ucp2, consistent with their lack of effect on mitochondrial membrane potential (Fig. 1c, right) .
To test directly the role of Ucp2 in engulfment, we knocked down endogenous Ucp2 expression in phagocytes via short interfering RNA (siRNA) (Supplementary Fig. 1e ). Ucp2 knockdown in NIH/3T3 cells led to increased mitochondrial membrane potential basally and during engulfment ( Fig. 1d and Supplementary Fig. 2f ). We observed two key phenotypes in Ucp2-depleted cells. First, Ucp2 knockdown phagocytes were less efficient engulfers, with a lower percentage of phagocytes ingesting apoptotic cells over a 6-h time course (Fig. 1e, left) . Second, Ucp2 knockdown reduced the phagocytic 'capacity' with a lower amount of apoptotic material being ingested per phagocyte (mean fluorescence intensity derived from the labelled apoptotic cells) (Fig. 1e, right) . Again, the uptake of synthetic targets was unaffected by Ucp2 knockdown (Fig. 1f) . These data indicated that phagocytes engulfing apoptotic cells upregulate Ucp2 and that Ucp2 expression influences phagocytic capacity.
To test whether overexpressing Ucp2 might provide a 'gain of function' for engulfing apoptotic cells, we transiently overexpressed Flagtagged Ucp2 in LR73 phagocytes. Ucp2-Flag was properly targeted to the mitochondria ( Supplementary Fig. 3a, b) , and Ucp2-Flag cells showed three striking phenotypes. First, a greater percentage of Ucp2-Flag cells ingested apoptotic cells, and this enhanced uptake depended on the known engulfment machinery components ( Fig. 2a and Supplementary Fig. 4a, b) . Second, in a time course, Ucp2-Flag cells continued to ingest apoptotic targets for up to 6 h whereas control-transfected LR73 cells reached a plateau by 2 h (Fig. 2b) . Ucp2-overexpressing cells had more ingested apoptotic cells per phagocyte (Fig. 2c, d) . Third, the rate of uptake of synthetic targets was unaffected in Ucp2-Flag cells ( Supplementary Fig. 4c ), suggesting a role for Ucp2 in sensing the metabolic load derived from apoptotic cells. Overexpression of Ucp2 homologues (Ucp1 or Ucp3; Supplementary Fig. 4d ) also promoted engulfment. Thus, higher levels of Ucp2 provide a gain-of-function phenotype, conferring a capacity for phagocytes to 'continue to eat' apoptotic cells.
Ucp2-Flag cells showed decreased mitochondrial membrane potential compared to controls (Fig. 2e) . The signal for MitoTracker, a dye that accumulates as the mitochondrial membrane potential increases 16 , was distinctly weaker in Ucp2-Flag-expressing cells compared to neighbouring non-transfected cells (Fig. 2f) . The drug genipin, which inhibits mitochondrial uncoupling by Ucp2 (ref. 17) , blunted the enhanced engulfment by Ucp2 ( Fig. 2g and Supplementary Fig. 4e ). As a parallel approach, we generated a Ucp2(D28N) mutant with decreased uncoupling activity 18, 19 . The Ucp2(D28N) mutant was expressed and localized to the mitochondria (as did wild type), yet Ucp2(D28N) failed to enhance engulfment of apoptotic cells ( Fig. 2h and Supplementary Fig. 4f) . Collectively, the decrease in mitochondrial membrane potential by Ucp2 correlates with enhanced and continued uptake of apoptotic cells.
We then asked whether the effect of Ucp2 could be mimicked by synthetic uncouplers that lower the mitochondrial membrane potential 20, 21 . We tested 2,4-dinitrophenol (2,4-DNP) and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) over a range of concentrations at which the total cellular ATP levels were unaltered and during engulfment. a, Increase in mitochondrial membrane potential in engulfing phagocytes. LR73 phagocytes were stained with JC-1 and incubated with cypHer5E-labelled apoptotic thymocytes or synthetic targets. Mitochondrial membrane potentials in engulfing and non-engulfing phagocytes within the same population (based on cypHer5E and pacific blue signal) were compared. Oligomycin-treated phagocytes served as a positive control for increased mitochondrial membrane potential. b, LR73 cells were incubated with cypHer5E-stained apoptotic thymocytes (3 h), washed to remove unengulfed targets, and further incubated for the indicated times, stained with JC-1 dye and analysed as above. c, LR73 cells were incubated with targets (apoptotic thymocytes from Ucp2 knockout mice or synthetic targets), and the mitochondrial fractions were immunoblotted for endogenous Ucp2. The mitochondrial membrane protein porin served as loading control. d, Mitochondrial membrane potential in control (Ctrl) or Ucp2 siRNA transfected NIH/3T3 (2 days post-transfection) was determined via JC-1 dye and flow cytometry. e, f, NIH/3T3 cells transfected with control or Ucp2-specific siRNA were incubated with apoptotic thymocytes stained with the dye TAMRA (e) or synthetic targets (f) and the percentage of cells engulfing targets (left) and phagocytic capacity (using the apoptotic-cell-derived fluorescence per phagocyte) were determined. Data are shown as mean 6 standard deviation (s.d.) and are representative of at least two independent experiments. *P , 0.05, **P , 0.01, ***P , 0.001.
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the phagocytes appeared morphologically similar to controls (Supplementary Fig. 5a , b). Both 2,4-DNP and FCCP significantly enhanced the uptake of apoptotic thymocytes by LR73 phagocytes (Fig. 3a) ; this increased uptake correlated with decreased mitochondrial membrane potential induced by these drugs ( Supplementary Fig.  5c, d ). Synthetic uncoupling also promoted phagocytes to continue to ingest multiple apoptotic cells over a time course (similar to Ucp2 overexpression) (Fig. 3b, c and Supplementary Fig. 5g ). To test whether mitochondrial membrane potential itself was the signal for enhanced engulfment capacity-that is, independent of increased proton leak and electron transport chain flux-we tested sodium azide, an inhibitor of complex IV of the electron transport chain that slows electron transport flux and lowers mitochondrial membrane potential.
At sodium azide concentrations that did not affect cellular ATP levels, it enhanced engulfment with a progressive decrease in the mitochondrial membrane potential ( Fig. 3a and Supplementary Fig. 5e , f). Higher sodium azide concentrations that lower cellular ATP levels did block engulfment (an ATP-dependent process) ( Fig. 3a and Supplementary Fig. 5f ).
We next asked whether raising the mitochondrial membrane potential would dampen engulfment. Oligomycin, an inhibitor of ATP synthase, increased the mitochondrial membrane potential within phagocytes and strongly inhibited engulfment (Fig. 3d) . The concentration of oligomycin used here affected the mitochondrial membrane potential but did not alter cellular ATP levels ( Supplementary Fig. 5h, i) . To test whether modulating the metabolic state of the phagocytes would affect apoptotic cell engulfment, we cultured phagocytes in glucose-free medium that decreased mitochondrial membrane potential, and in turn enhanced apoptotic cell engulfment ( Supplementary Fig. 6a, b) . Conversely, excess glucose (leading to higher mitochondrial membrane potential) reversed the effect of Ucp2 overexpression or FCCP ( Fig. 3e and Supplementary Fig. 6c-e) . Thus, the mitochondrial membrane potential within phagocytes is a critical determinant in regulating phagocytic capacity and continued uptake by phagocytes.
Increased metabolic load in phagocytes during engulfment may affect many aspects of metabolism. As Ucp2 is known to increase b-oxidation and decrease reactive oxygen species (ROS) production 8 , perhaps excess cellular lipids or ROS feedback could slow down the engulfment pathway. Incubating phagocytes with apoptotic thymocytes (but not synthetic targets) increased the rate of fatty acid oxidation ( Supplementary Fig. 7a, b) ; however, both Ucp2-overexpressing cells and Ucp2-deficient phagocytes showed higher fatty acid oxidation rates ( Supplementary Fig. 7c, d ), yet they have opposite phenotypes in apoptotic cell engulfment. This suggested that the possible effect of Ucp2 on lipid oxidation alone is not a major regulator of apoptotic cell clearance.
Ucp2 has also been shown to decrease ROS levels, which could be a potential mechanism by which Ucp2 promotes continued engulfment. However, increasing phagocyte mitochondrial ROS levels via the drugs rotenone or antimycin A (blocking complexes I or III within the electron transport chain, respectively) did not decrease apoptotic cell engulfment ( Supplementary Fig. 8a, b) . Rather, these drugs modestly increased phagocytosis, probably owing to the decreased mitochondrial membrane potential. Furthermore, ameliorating ROS with FCCP, overexpression of the mitochondrial antioxidant enzyme superoxide dismutase 2 (SOD2), or scavenging ROS with well-known scavengers (Tiron or MitoTEMPO) did not increase engulfment ( Supplementary Fig. 8a-g ). PGC1a, the master transcription factor for mitochondrial biogenesis, was not altered during engulfment and overexpressing PGC1a did not promote engulfment of apoptotic cells (data not shown and Supplementary Fig. 8h ). Moreover, neither the AMPK nor the mTOR signalling pathways were activated during engulfment ( Supplementary Fig. 8i, j) . While these data cannot rule out a contribution of b-oxidation and ROS, they could not provide a mechanistic reason for Ucp2 function during apoptotic cell engulfment. Ucp2-mediated regulation of the phagocyte mitochondrial membrane potential seemed to correlate best with continued phagocytosis of apoptotic cells.
To determine whether signalling via specific engulfment receptors may link to Ucp2/mitochondrial signalling, we generated LR73 cells overexpressing the phosphatidylserine receptor Tim-4 (LR73 cells). Tim-4 overexpression led to increased apoptotic cell engulfment 6, 22, 23 . Three lines of data indicated a link between Tim-4-mediated apoptotic cell recognition and Ucp2. First, although there was no difference in the basal Ucp2 level between control and LR73 Tim-4 cells, the latter upregulated Ucp2 to a higher level (Fig. 3f, top) . Importantly, synthetic targets did not increase Ucp2 expression, even though Tim-4 overexpression promotes uptake of synthetic targets (Fig. 3f, bottom) . Second, LR73
Tim-4 cells continued to take up multiple apoptotic cells (as indicated by mean fluorescence intensity (MFI)), consistent with (Fig. 3g) . Third, the Ucp2 inhibitor genipin blocked Tim-4-mediated enhanced uptake (Fig. 3h) . We also tested whether synthetic uncoupling or Ucp2 overexpression affected Tim-4 levels. However, surface expression of endogenous Tim-4 or haemagglutin-tagged (HA)-Tim-4 was unaffected by Ucp2 overexpression, Ucp2 deficiency, synthetic uncoupling or by scavenging ROS (Supplementary Fig. 9a-e) . These data indicate a link between apoptotic cell recognition at the membrane and the mitochondrial membrane potential of phagocytes, with Ucp2 serving as a molecular intermediate.
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We next addressed the relative importance of Ucp2 in apoptotic cell clearance in vivo using Ucp2-deficient mice 10, 12 . Bone-marrow-derived macrophages (BMDMs) from Ucp2 2/2 mice had a higher mitochondrial membrane potential compared to controls (Fig. 4a) . In vitro, BMDMs from Ucp2 2/2 mice consistently showed lower phagocytic capacity for apoptotic cells (Fig. 4b) , but no defect in uptake of synthetic targets, live or dead bacteria, or zymosan particles ( Fig. 4c and Supplementary Fig. 10a-f ). This suggested that use of Ucp2 for apoptotic cell clearance is dependent both on the metabolic load (absent in synthetic targets) and on the nature of phagocytosis (for example, bacteria and yeast that do carry a metabolic load are taken up via other types of phagocytic receptors). There was residual engulfment in Ucp2-null phagocytes, which may in part be due to the upregulation of Ucp3 seen in 6-day cultures of cells from Ucp2 2/2 mice ( Supplementary Fig.  11a-c) .
We next asked how Ucp2 2/2 phagocytes clear apoptotic cells when a significant population of cells within a tissue are undergoing apoptosis. Injection of dexamethasone induces rapid and synchronous death of thymocytes, and the subsequent clearance of apoptotic thymocytes by resident phagocytes can provide a quantitative in vivo model of apoptotic cell clearance 24 . Whereas control mice show a decrease in overall thymic size at 6 h after dexamethasone injection, Ucp2 2/2 mice showed only a limited reduction in thymic size after dexamethasone injection (Fig. 4d) . The absolute number of cells confirmed that dexamethasone-injected Ucp2 2/2 mice had much higher total thymic cell numbers compared to controls (Fig. 4e) . Ucp2 2/2 thymocytes underwent apoptosis comparable to control littermates ( Supplementary Fig.  12a, b) ; moreover, the migration of monocytes or macrophages towards find-me signals from apoptotic cells was unaffected by Ucp2 levels or mitochondrial uncoupling ( Supplementary Fig. 13a-e) . mice assessed by JC-1 staining. b, Engulfment of TAMRA-labelled apoptotic thymocytes by BMDMs from Ucp2 1/1 and Ucp2 2/2 mice was assessed over a time course. The less pronounced effect of BMDM cultures could be due to compensatory Ucp3 upregulation (see Supplementary Fig. 11) 
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Thus, the increased thymic cellularity in dexamethasone-treated Ucp2 2/2 mice resulted from defective clearance. The thymuses of dexamethasone-treated Ucp2 2/2 mice consistently had higher levels of unengulfed corpses by TdT-mediated dUTP nick end labelling (TUNEL) and a threefold increase in TUNEL fluorescence, without altered density of F4/80-positive cells (Fig. 4f, g and Supplementary Fig.  13f-h ). We also tested the ability of Ucp2 2/2 mice to clear apoptotic cells in other tissues. By initiating acute apoptosis of germ cells in the testes via testicular torsion, we assessed the clearance of dying germ cells by Sertoli cells. The testes of Ucp2 2/2 mice contained increased numbers of uncleared apoptotic cells per seminiferous tubule compared to Ucp2 1/1 mice (Fig. 4h, i ). These data demonstrate an essential role for Ucp2 in apoptotic cell clearance in vivo.
Although significant recent progress has been made in understanding how phagocytes recognize and engulf apoptotic cells 25 , this work provides additional insights on this process. First, mitochondrial membrane potential critically controls how well a phagocyte can engulf apoptotic cells, with an inverse correlation between mitochondrial membrane potential and engulfment capacity. Second, the Ucp2 protein acts as a regulator of mitochondrial membrane potential within phagocytes during apoptotic cell engulfment, with a requirement for Ucp2 in efficient apoptotic cell clearance in vivo. Third, a previously unappreciated crosstalk exists between the mitochondria and the engulfment machinery within phagocytes, with the 'sensing' of the total mitochondrial membrane potential critically influencing phagocytic capacity. This has broad implications for apoptotic cell clearance in vivo, because failed clearance has been linked to inflammation and autoimmune diseases. Moreover, Ucp2 deficiency was linked to impaired pancreatic b-cell function and glucose-induced insulin secretion 26, 27 , and Ucp2 2/2 mice show increased atherosclerosis 11, 12, 28 . The data presented here provide a new and unexpected link between mitochondrial function, Ucp2 and apoptotic cell clearance and may help to provide a better understanding of the complex aetiology of metabolic diseases.
METHODS SUMMARY
To detect mitochondrial membrane potential, phagocytes (LR73, NIH/3T3 or BMDMs) 14, 24 were stained with Mitotracker Deep Red FM, TMRE or JC-1, incubated with apoptotic cells and analysed by flow cytometry. Cell clearance in the thymus was analysed as detailed previously 24 . Testicular torsion was performed as per the guidelines of the Society for the Study of Reproduction.
METHODS
Cell culture and transfections. LR73 cells were cultured in a-MEM, whereas NIH/3T3 cells and J774 macrophage cells were maintained in DMEM and Jurkat cells were cultured with RPMI, along with 10% FBS and 1% penicillinstreptomycin-glutamine. SCI cells were cultured in a-MEM and 1 mM of sodium pyruvate. LR73 cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. NIH/3T3 cells were nucleofected using amaxa nucleofector (kit R, program U-030) or transfected with Lipofectamine 2000 according to the manufacturer's instructions. Primary cell culture. Bone marrow cells from 6-week-old mice were cultured in RPMI medium with 10% FBS, 1% penicillin-streptomycin-glutamine, and 10% L929 cell conditioned medium. Two or six days later, more than 85% of the adherent cells were F4/80 positive and 95% of the cells were CD11b positive. Resident peritoneal cells were collected from 6-week-old mice and plated with RPMI supplemented with 10% FBS and 1% penicillin-streptomycin-glutamine. Four hours later, floating cells were washed with warm PBS twice and adherent cells were regarded as resident peritoneal macrophages and used in further assays. Plasmids and mutagenesis. All constructs generated were sequenced to confirm fidelity and the presence of the appropriate mutations. The pEBB-Ucp2 and pEBB-Ucp2-Flag constructs were generated from the Ucp2 cDNA templates by a PCR-based strategy in the pEBB-Flag vector. pEBB-Ucp2(D28N) was generated by site-directed mutagenesis. ELMO, Dock180, Rac, BAI1 and Tim-4 constructs used in this study have been described previously 19 .
Immunoblotting and antibodies. The antibodies used were anti-Ucp2 (Santa Cruz Biotechnology, C-20), anti-Flag (Sigma, M-2), anti-porin (Abcam, ab15895), anti-Erk2 (Santa Cruz, C-14) and anti-AIF (Cell Signaling, D39D2). PhosphoAMPKa (Thr 172), AMPKa antibody, phospho-p70 S6 kinase (Thr 389) and p70 S6 kinase were purchased from Cell Signaling Technology. To detect endogenous Ucp2, it is necessary to isolate mitochondria. For the isolation of mitochondria, cells were resuspended in 500 ml of TS buffer (10 mM Tris, pH 7.5, 250 mM sucrose, 2 mg ml 21 DNase and protease inhibitor cocktail), and then subjected to three cycles of 5-min freezing in liquid nitrogen followed by 10-min thawing at 37 uC. Unbroken cells and nuclei were removed by centrifugation at 800g for 10 min and mitochondria were collected from the supernatant by centrifugation at 10, 000g for 20 min. The isolated mitochondria were lysed in RIPA buffer and subjected to immunoblotting. To measure induction of Ucp2 during apoptotic cell engulfment, 2.0 3 10 6 LR73 cells were plated on a 100-mm culture dish 2 days before 1.0 3 10 8 apoptotic thymocytes in 10 ml of a-MEM were added. After incubation for 3 h, the mitochondria were isolated and the Ucp2 levels were analysed. For BMDMs, 5.0 3 10 6 BMDMs were plated on a 100-mm Petri dish 1 day before the assay. The next day, 1.0 3 10 8 apoptotic thymocytes in 10 ml of RPMI were added to the BMDMs and incubated for 1 h. The cells were extensively washed with cold PBS and trypsinized and analysed for Ucp2 levels. To detect overexpressed Ucp2, LR73 cells were transiently transfected with Flag-tagged Ucp2 using Lipofectamine 2000 (Invitrogen). One day after transfection, the cells were lysed and subjected to immunoblotting against the respective tags or endogenous proteins. Immunofluorescence microscopy. NIH/3T3 fibroblasts were plated on glass chamber slides and transfected with Flag-Ucp2 either alone or in combination with YFP-Rab5 or YFP-Rab7. To stain lysosomes or mitochondria, cells were incubated with Lysotracker Red (1:10,000 dilution) or Mitotracker Deep Red (100 nM) in DMEM/10% FBS for 20 min. Cells were then fixed with 3% paraformaldehyde (Sigma) in PBS for 30 min, permeabilized with 0.1% Triton X-100 (Sigma) and blocked with 5% milk that had been clarified by high-speed centrifugation. Antibody staining was then performed using antibodies to Flag (clone M5, Sigma) and/or AIF (D39D2, Cell Signaling) detected with either Alexa 488 or Alexa-555 goat anti-mouse and/or Alexa-555 goat anti-rabbit antibodies (highly cross-absorbed, Invitrogen), respectively. YFP was detected using an Alexa-488 anti-GFP antibody (Invitrogen). The stained cells were analysed by Axio imager 2 with Apotome (Zeiss). Quantitative RT-PCR. Total RNA was isolated using the RNeasy Mini Kit (Qiagen) and cDNA was generated from total RNA with Superscript III (invitrogen) according to the manufacturers' protocol. Ucp1, Ucp2 and Ucp3 mRNA were detected by PCR using cDNA as template. For siRNA transfected NIH/3T3 cells and Ucp2 knockout mice, relative Ucp2 or Ucp3 mRNA levels were determined by normalizing to Hprt using the StepOnePlus qPCR system (Applied Biosystems). Phagocytosis assay. Phagocytosis assays were performed as described previously 14 . 1.0 3 10 5 LR73 cells were transiently transfected in triplicates with the indicated plasmids either with GFP or GFP fusion proteins in a 24-well plate. The cells were incubated with apoptotic thymocytes or 2 mm carboxylate-modified red fluorescent beads (invitrogen), which mimic the negative charge on apoptotic cells and can serve as simplified targets. For the induction of apoptosis, thymocytes were incubated with 50 mM dexamethasone (Calbiochem) at 37 uC for 4 h. The thymocytes were resuspended to a final concentration of 1.0 3 10 7 cells per 300 ml with a-MEM (or cell culture medium for specific cell types) supplemented with 2% FBS and 0.2% penicillin-streptomycin-glutamine for the phagocytosis assay of LR73. The transfected cells were incubated with 300 ml of the apoptotic thymocyte resuspension in a 5% CO 2 incubator at 37 uC for the desired time. After incubation of the phagocytes with targets, the phagocytes were extensively washed with cold PBS, trypsinized, resuspended in cold medium (with 1% NaN 3 ), and analysed by two-colour flow cytometry (FACSCalibur from BD). The transfected cells were recognized by their GFP fluorescence and targets were recognized by red fluorescence (carboxylate-modified red fluorescent beads or apoptotic thymocytes). Forward and side-scatter parameters were used to distinguish free unbound targets from phagocytes. The majority of 'double-positive' cells scored in the FACS assay represented targets engulfed by phagocytes, or targets in the process of being engulfed. The MFI in the red channel of the cells taking up targets provided an indication of the capacity of uptake (proportional to the number of particles taken up). For measuring phagocytosis by BMDMs, 2.0 3 10 4 BMDMs were plated in the 24-well plate one day before the phagocytosis assay. Next day, the cells were incubated with 2.0 3 10 6 TAMRA-stained apoptotic thymocytes for the desired time and analysed for engulfment as above. Internalization assay. Thymocytes were double stained with TAMRA (25 mM) and cypHer5E (1 mM; GE Healthcare) and the phagocytosis assay was performed as described above. TAMRA and cypHer5E high-double-positive cells were considered to be phagocytes internalizing apoptotic cells, and TAMRA-positive but cypHer5E-low cells were regarded as bound but uninternalized targets on phagocytes. Phagocytosis of dead Escherichia coli, Staphylococcus aureus and zymosan. 2.0 3 10 4 BMDMs from wild-type or Ucp2-deficient mice were plated on a well of a 24-well plate. Next day, BMDMs were incubated with alexa-488 conjugated 5 3 10 6 E. coli and S. aureus or 5 3 10 5 zymosan particles (Invitrogen) for the desired time. Unbound targets were extensively washed with cold PBS five times and BMDMs were trypsinized and subjected to FACS analysis. Alexa-488-positive BMDMs were considered to be phagocytes engulfing targets. Gentamicin protection assay for bacterial internalization. Quantification of intracellular bacteria was done using the gentamicin protection assay. 2 3 10 5 BMDMs per well were seeded into a 24-well culture dish 18 h before infection at a multiplicity of infection of 10 for 1 h in antibiotic-free media in a 37 uC CO 2 incubator. Cells were then washed and incubated with gentamicin for 90 min to kill extracellular bacteria. Subsequently, cells were lysed in 1% Triton-X 100, lysates were serially diluted, and plated directly onto Luria-Bertani agar plates. Total colony-forming units (c.f.u.) were enumerated the next day after overnight incubation at 37 uC. Values were standardized to levels of colonization in control cell preparations. Ucp2 knockdown. NIH/3T3 cells were nucleofected according to the manufacturer's manual (Kit R, U-030, amaxa) with minor modifications. 1.0 3 10 6 cells were nucleofected with 6 picomoles per sample control or Ucp2 siRNA (Dharmacon Ucp2 smart pool) and plated onto 3 wells of a 6-well plate. Twenty-four hours after nucleofection, the cells were trypsinized and 2.0 3 10 4 cells were replated in the 12-well plate. Two days after nucleofection, the cells were incubated with 1.0 3 10 6 TAMRA-stained apoptotic SCI or Jurkat cells in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin-glutamine at 37 uC for the desired time. Measurement of mitochondrial membrane potential. To detect the mitochondrial membrane potential, cells treated with the indicated experimental conditions were stained with Mitotracker Deep Red FM (Invitrogen), the accumulation of which in mitochondria is dependent on mitochondrial membrane potential. Mitochondrial membrane potential was also measured using TMRE (Invitrogen) or a dual emission potential-sensitive probe, JC-1 dye (SIGMA-Aldrich), according to the manufacturer's protocol. For TMRE staining, cells were incubated with 50 nM of TMRE in culture medium in a 5% CO 2 incubator at 37 uC for 30 min and fluorescence coming from cells was measured by flow cytometry. For JC-1 staining, cells in a 24-well plate were incubated with 1 ml of mitochondrial staining solution containing the 50% medium used for cell growth and 2.5 mg ml 21 of JC-1 dye in a 5% CO 2 incubator at 37 uC for 20 min. The cells were then washed twice with warm PBS and trypsinized. Overflow of green fluorescent signal to red fluorescence was compensated and the intensity of red fluorescence coming from JC-1 aggregates was detected by flow cytometry using the FACSCalibur instrument (Becton Dickinson). Measurement of intracellular ATP. Intracellular ATP levels were measured using CellTiter-Glo Luminescent Cell Viability Assay kit (Promega) according to the manufacturer's manual. Cells were treated with experimental conditions and trypsinized. 2.5 3 10 4 cells per 50 ml were added into a well of a 96-well plate. Then, 50 ml of CellTiter-Glo Reagent was added to the well containing the cells. The cells were incubated on an orbital shaker for 2 min and followed by incubation LETTER RESEARCH at room temperature (25 uC) for 10 min. Luminescence was measured using MicroBeta TriLux (EG&G WALLAC). Analysis of cell clearance in the thymus. Five-to-six-week-old wild-type and Ucp2-deficient mice were intraperitoneally injected with 300 ml of PBS containing 250 mg dexamethasone dissolved in ethanol (10 mg ml 21 ). Six hours after injection, the mice were killed and thymuses were extracted. For quantification of thymic cellularity, thymocytes were resuspended with HBSS supplemented with 5% FBS. The cells were diluted and mixed with 50 ml of quantification beads (Spherotech). The mixture was subjected to flow cytometryic analysis to allow for the quantification of thymocytes. To monitor the presence of TUNEL-positive uncleared apoptotic cells, 6 h after injection thymuses from the mice were extracted and embedded in O.C.T. compound. The O.C.T.-compound-embedded thymuses then were frozen in liquid nitrogen. After that, thymic cryosections on glass slides were stained using the In situ Cell Death Red kit according to manufacturer's instructions (Roche). Sections were mounted with Prolong Antifade plus DAPI medium and analysed by Axio Imager 2 with Apotome (ZEISS). To monitor ex vivo apoptosis of thymocytes, 1.0 3 10 7 thymocytes from 5 to ,6-week-old Ucp2 wild-type and deficient littermate mice were incubated with 50 mM dexamathasone at 37 uC for 4 or 6 h. The cells were washed with PBS once and then stained with annexin V and propidium iodide (Annexin V: FITC apoptosis detection kit II, BD). Cell migration assay. 2 3 10 6 cells ml 21 THP-1 cells were resuspended with RPMI containing 5% FBS, 1% penicillin, streptomycin and glutamine and 10 mM HEPES and were pre-incubated with the desired concentration of FCCP for 1 h. Five-hundred microlitres of apoptotic supernatant or MCP-1 (25 ng ml
21
) was added to the lower chamber of a 24-well plate with a 5-mm pore size transwell (5-mm pore size, Corning) and 100 ml of cells (2 3 10 6 cells ml
) were loaded on the upper chamber of the plate and then incubated at 37 uC for 1 h. The percentage of migrated cells was determined by FACS with 5.1-mm AccuCount beads and compared to input cells. For BMDM migration, 4.0 3 10 5 cells ml 21 were resuspended in RPMI containing 1% BSA, 1% penicillin, streptomycin and glutamine and 10 mM HEPES. Five-hundred microlitres of apoptotic supernatant or Sdf-1 (50 ng ml 21 ) was added to the lower chamber of a 24-well transwell plate and 100 ml of BMDMs was added on the upper chamber and incubated at 37 uC for 3 h. The number of BMDMs that migrated on the underside of the membrane was determined by Diff-Quick staining and counted using microscopy. Thymus staining. Tissue sections were blocked for 15 min with 2% normal goat serum and then were stained for 60 min at 25 uC with PE-conjugated F4/80 (eBioscience) and FITC-conjugated anti pan-cytokeratin (Sigma). After incubation, slides were washed three times in PBS and then mounted with GelMount (Molecular Probes, Invitrogen). Fatty acid oxidation assay. Phagocytes were seeded in a 12-well plate at a density of 2 3 10 5 cells per well on the day before the fatty acid oxidation
